These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 648586)

  • 1. Single dose and cross tolerance studies of beta-phenethylamine, d-amphetamine and LSD in the chronic spinal dog.
    Vaupel DB; Nozaki M; Martin WR; Bright LD
    Eur J Pharmacol; 1978 Apr; 48(4):431-7. PubMed ID: 648586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pharmacologic comparison of 3,4-methylenedioxyamphetamine and LSD in the chronic spinal dog.
    Nozaki M; Vaupel DB; Martin WR
    Eur J Pharmacol; 1977 Dec; 46(4):339-49. PubMed ID: 590343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pharmacological comparison of 3-methoxy-4,5-methylenedioxyamphetamine and LSD in the dog.
    Nozaki M; Vaupel DB; Bright LD; Martin WR
    Drug Alcohol Depend; 1978 May; 3(3):153-63. PubMed ID: 668489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The identification of LSD-like hallucinogens using the chronic spinal dog.
    Martin WR; Vaupel DB; Nozaki M; Bright LD
    Drug Alcohol Depend; 1978 Mar; 3(2):113-23. PubMed ID: 272982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Responses of the flexor reflex to LSD, tryptamine, 5-hydroxytryptophan, methoxamine, and d-amphetamine in acute and chronic spinal rats.
    Nozaki M; Bell JA; Vaupel DB; Martin WR
    Psychopharmacology (Berl); 1977 Nov; 55(1):13-8. PubMed ID: 414256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross tolerance to tryptamine in the LSD tolerant dog.
    Martin WR; Eades CG
    Psychopharmacologia; 1972; 27(2):93-8. PubMed ID: 4638212
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparison of LSD-25 with (-)-delta-9-trans-tetrahydrocannabinol (THC) and attempted cross tolerance between LSD and THC.
    Isbell H; Jasinski DR
    Psychopharmacologia; 1969; 14(2):115-23. PubMed ID: 5350620
    [No Abstract]   [Full Text] [Related]  

  • 8. Relationship of CNS tryptaminergic processes and the action of LSD-like hallucinogens.
    Martin WR; Sloan JW
    Pharmacol Biochem Behav; 1986 Feb; 24(2):393-9. PubMed ID: 3006088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Actions of amphetamine and antagonists on pupil diameter in the chronic sympathectomized dog.
    Sharpe LG; Pickworth WB; Martin WR
    Psychopharmacology (Berl); 1977 Jul; 53(2):115-20. PubMed ID: 408837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OBSERVATIONS ON DIRECT AND CROSS TOLERANCE WITH LSD AND D-AMPHETAMINE IN MAN.
    ROSENBERG DE; WOLBACH AB; MINER EJ; ISBELL H
    Psychopharmacologia; 1963 Oct; 5():1-15. PubMed ID: 14085622
    [No Abstract]   [Full Text] [Related]  

  • 11. The action of tryptamine on the dog spinal cord and its relationship to the agonistic actions of LSD-like psychotogens.
    Martin WR; Eades CG
    Psychopharmacologia; 1970; 17(3):242-57. PubMed ID: 5310035
    [No Abstract]   [Full Text] [Related]  

  • 12. Sigma effects of nalorphine in the chronic spinal dog.
    Gilbert PE; Martin WR
    Drug Alcohol Depend; 1976 Oct; 1(6):373-6. PubMed ID: 189982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of 2,3-dihydro-lysergic acid diethylamide with LSD-25.
    Gorodetzky CW; Isbell H
    Psychopharmacologia; 1964 Sep; 6(3):229-33. PubMed ID: 5319153
    [No Abstract]   [Full Text] [Related]  

  • 14. Usefulness of an animal behavioral model in studying the duration of action of LSD and the onset and duration of tolerance to LSD in the cat.
    Trulson ME; Jacobs BL
    Brain Res; 1977 Aug; 132(2):315-26. PubMed ID: 890483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between pentazocine and tripelennamine on autonomic and nociceptive measures in the dog.
    Vaupel DB
    Pharmacol Biochem Behav; 1989 May; 33(1):245-51. PubMed ID: 2780781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central action of phenylethylamine in rats.
    Jagiełło-Wójtowicz E
    Pol J Pharmacol Pharm; 1981; 33(1):59-71. PubMed ID: 7196039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral tolerance to lysergic acid diethylamide is associated with reduced serotonin-2A receptor signaling in rat cortex.
    Gresch PJ; Smith RL; Barrett RJ; Sanders-Bush E
    Neuropsychopharmacology; 2005 Sep; 30(9):1693-702. PubMed ID: 15756304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Quantitative analysis of repeated electroencephalograms in the dog under the effects of diethyl lysergamide (LSD25)].
    Guiti N; Djahanguiri B; Mehdizadeh H
    Electroencephalogr Clin Neurophysiol; 1966 Jul; 21(1):80-4. PubMed ID: 4165370
    [No Abstract]   [Full Text] [Related]  

  • 19. Interactions between norepinephrine antagonists and potentiators (chlorpromazine, chlorpromazine sulfoxide and imipramine) and sympathetic amines (amphetamine and methoxamine) on the flexor reflex of the chronic spinal dog.
    Martin WR; Eades CG
    Int J Neuropharmacol; 1968 Nov; 7(6):493-501. PubMed ID: 5253333
    [No Abstract]   [Full Text] [Related]  

  • 20. Dissociations between the effects of hallucinogenic drugs on behavior and raphe unit activity in freely moving cats.
    Trulson ME; Heym J; Jacobs BL
    Brain Res; 1981 Jun; 215(1-2):275-93. PubMed ID: 6114779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.